Bristol Myers Squibb (BMY) stock analysis and AI score
Bristol Myers Squibb has a Peakwise AI stock score of 57 out of 100, a mixed profile, ranked 20 of 51 stocks as of Nov 6, 2026. The score describes price history and ratios. It is no advice.
Ranked 20 of 51 by AI score
End of day data as of Nov 6, 2026
AI Score Parts. Weights and values.
The Bristol Myers Squibb score is a weighted average of 6 parts. Each part ranks the stock from 0 to 100 against the other 50 stocks on the list, and 100 is the best rank.
Quality and valuation use company ratios such as net margin, debt and earnings yield.
- Momentum weight 30%57
- Trend weight 20%44
- Volatility weight 15%56
- Drawdown weight 15%79
- Quality weight 10%31
- Valuation weight 10%81
Price and Range. End of day Nov 6, 2026.
$62.14
Last close of BMY in US dollars, as of Nov 6, 2026. Not a live quote.
- 1 month
- +4.3%
- 6 months
- +10.6%
- 1 year
- +33.7%
What This Score Means. Mixed profile.
A score of 57 gives Bristol Myers Squibb a mixed profile. Mixed means the score sits between the weak and the strong bands.
Valuation is the strongest part at 81, weighted 10%. It looks at earnings yield and free cash flow yield. Quality is the weakest at 31, weighted 10%. It looks at net margin and debt.
As of Nov 6, 2026 the last close was $62.14. Bristol Myers Squibb sits 7 points above the middle of the list (a median of 50).
A mixed score is no warning and no green light. Read the parts to see where it comes from.
About Bristol Myers Squibb. Pharmaceuticals.
Bristol Myers Squibb develops medicines for cancer, blood disorders, heart disease and immune conditions. Opdivo and Eliquis, the latter sold together with Pfizer, are among its main products. It bought Celgene in 2019, a deal that reshaped its drug lineup.
- Ticker
- BMY
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Headquarters
- United States
Similar Stocks. Same sector first.
- DanaherDHR · Health Care57Danaher stock analysis and AI score
- Thermo FisherTMO · Health Care63Thermo Fisher stock analysis and AI score
- Eli LillyLLY · Health Care64Eli Lilly stock analysis and AI score
- UnitedHealthUNH · Health Care48UnitedHealth stock analysis and AI score
See every stock on the AI stock scores leaderboard, or sort and filter the same list with the AI stock finder.
Score FAQ. About Bristol Myers Squibb.
Research, not advice
Peakwise is a research tool. The AI score of Bristol Myers Squibb describes end of day price history and a few ratios compared with other large US stocks. It is not investment advice, a forecast or a recommendation to buy or sell. Read how it works on the AI stock score methodology page, or use the AI stock analysis tool for risks and a fair value range.
Go deeper. Past the score.
The score is the short version. The AI stock analysis of Bristol Myers Squibb adds financials, a fair value range, analyst views and risks.